Published: 2019-01-28

Primary adenocarcinoma arising from ileo-cecal junction presented with a component of ileo-ileal intussusception

Satyendra Ramnadh G., Vikas Puppala, Vishnu Samrat, M. Vijaya Lakshmi, Shekar Y. Tati, Ravindra Nadh, Mrudula .


Primary adenocarcinoma arising from small bowel is a rare entity account 1-2% of all GIT malignancies. Adenocarcinoma is the second most malignant lesion of the small bowel after carcinoid tumour followed by lymphoma and GISTs. Duodenum is the common site followed by jejunum and ileum within the small bowel. About 48years old male presented with symptoms and signs of intestinal obstruction i.e. pain and distension of the abdomen with bilious vomiting and absolute constipation. Case was diagnosed as intestinal obstruction provisionally. USG reported as ileocecal intussusceptions with mesenteric lymphadenopathy and was confirmed by CECT. After laparotomy, growth was found at ileocecal junction. Right hemicolectomy along with lymphadenectomy was done and specimen sent for HPE. HPE revealed well differentiated adenocarcinoma, arising from terminal ileum at ileocecal junction with ileo-ileal intussusception. Small bowel adenocarcinoma is rare, further rare in ileocecal junction, radiologically presented as ileo-cecal intussusception. However, lymph nodal enlargement put us in diagnostic dilemma. Author are interested to report this case because of its rarity (incidence of adenocarcinoma terminal ileum is extremely rare and presentation as intussusception is diagnostic challenging.



Contrast enhanced computed tomography, Gastro intestinal stromal tumor, Histopathological examination, Ileocecal junction, Small bowel adenocarcinoma

Full Text:



Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199(6):797-803.

Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20years. Ann Surg. 2009;249(1):63-71.

Shenoy S. Primary small-bowel malignancy: update in tumor biology, markers, and management strategies. J Gastrointestinal Cancer. 2014;45(4):421-30.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer: Interdisciplinary Inter J Am Cancer Soc. 2004;101(3):518-26.

Krishnamurthy P, Varghese SE, Gopalswamy N, Hillman N, Ali SA. Small-bowel adenocarcinoma: case report and review of literature on diagnosis of small-bowel tumors. Gastroenterol Hepatol. 2007;3(2):129.

Beltrán MA, Barría C, Contreras MA, Wilson CS, Cruces KS. Adenocarcinoma in intestinal duplication of the ileum: Case report. Med J Chile. 2009 Oct;137(10):1341-5.

Adad SJ, Camara CA, Pereira JM, Carmo Jr JD, Micheletti AM. Multicenter primary adenocarcinoma with 12 foci: case report and literature review. Brazilian J Coloproctol. 2011 Jun; 31 (2): 205-9.

Guo X, Mao Z, Su D, Jiang Z, Bai L. The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors. Med Oncol. 2014;31(4):913.

Gil MF, García MG, Fernández MP, López-Jurado RT. Polyps and neoplasms of the small intestine. Malform Vascular Inj Med-Accred Continuing Med Educ Prog. 2008; 10 (4): 223-30.

Korman MU. Radiologic evaluation and staging of small intestine neoplasms. Euro J Radiol. 2002;42(3):193-205.

Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol. 2007;14(8):2263-9.

Czaykowski P, Hui D. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency. Clin Oncol. 2007;19(2):143-9.

Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27(16):2598-603.

Cao J, Zuo Y, Lv F, Chen Z, Li J. Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients. J Clin Gastroenterol. 2008;42(2):167-73.